Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Gentamicin implant - Innocoll

Drug Profile

Gentamicin implant - Innocoll

Alternative Names: Cogenzia; CollaRx; CollaRx® gentamicin topical - Innocoll; Collatamp EG; Collatamp G; Collatamp G topical; Cronocol; Duracoll; Garacol; Garacoll; Garamycin Schwamm; Gentacol; Gentacoll; Gentalyn; Gentamicin surgical implant - Innocoll; Gentamicin-collagen Topical; Gentimplant; INL-002; Sulmycin Implant; Sulmycin Implant E; Sulmycin Schwamm

Latest Information Update: 08 Feb 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Essex Chemie; Innocoll
  • Developer Innocoll; Premier Research Group
  • Class Aminoglycosides; Anti-infectives; Antibacterials; Small molecules
  • Mechanism of Action Protein 30S ribosomal subunit inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Postoperative infections
  • Phase III Diabetic foot ulcer

Most Recent Events

  • 06 Feb 2019 Aralez Pharmaceuticals is now called Old API Wind-down
  • 08 Jan 2019 Shire has been acquired and merged into Takeda
  • 11 Jul 2018 EUSA Pharma enters into an agreement to sell its critical care business including Collatamp® SERB Pharmaceuticals
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top